Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0759571B2 - Process for producing 1,3-oxazolidin-2-one derivative - Google Patents
[go: Go Back, main page]

JPH0759571B2 - Process for producing 1,3-oxazolidin-2-one derivative - Google Patents

Process for producing 1,3-oxazolidin-2-one derivative

Info

Publication number
JPH0759571B2
JPH0759571B2 JP62027741A JP2774187A JPH0759571B2 JP H0759571 B2 JPH0759571 B2 JP H0759571B2 JP 62027741 A JP62027741 A JP 62027741A JP 2774187 A JP2774187 A JP 2774187A JP H0759571 B2 JPH0759571 B2 JP H0759571B2
Authority
JP
Japan
Prior art keywords
compound represented
general formula
reaction
group
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62027741A
Other languages
Japanese (ja)
Other versions
JPS63196574A (en
Inventor
光夫 真崎
直哉 森藤
弘一 箸本
Original Assignee
日本ケミフア株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本ケミフア株式会社 filed Critical 日本ケミフア株式会社
Priority to JP62027741A priority Critical patent/JPH0759571B2/en
Publication of JPS63196574A publication Critical patent/JPS63196574A/en
Publication of JPH0759571B2 publication Critical patent/JPH0759571B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 本発明は、次の一般式(I) (式中、nは4〜6の整数を示し、*は、光学活性を示
す) で表わされる光学活性1,3−オキサゾリジン−2−オン
誘導体及びその酸付加塩の製造に関する。
The present invention provides the following general formula (I) (In the formula, n represents an integer of 4 to 6, and * represents optical activity.) The present invention relates to the production of an optically active 1,3-oxazolidin-2-one derivative and an acid addition salt thereof.

下記一般式(I′) (式中、nは前記と同じ) で表わされる1,3−オキサゾリジン−2−オン誘導体は
本発明者らにより、優れたグルタミン酸遮断作用及び貧
血性除脳固縮標本に対する固縮緩解作用を有し、医薬品
及び農薬として有用な化合物であることが見い出されて
いる。(特開昭61-83170) 一般的に、このような化合物の光学活性体を得るために
は、原料から目的物に至る経路のどこかで光学分割を行
う必要が生じ、かかる光学分割を行うためには高価な光
学分割剤が必要で、又場合により保護基等の導入という
余分な工程が必要となる。
The following general formula (I ') (In the formula, n is the same as above), the 1,3-oxazolidin-2-one derivative represented by the present inventors has an excellent glutamate-blocking action and a solid-contraction-releasing action for anemia decerebrate rigidified specimens. However, they have been found to be useful compounds as pharmaceuticals and agricultural chemicals. (Japanese Patent Laid-Open No. 61-83170) Generally, in order to obtain an optically active substance of such a compound, it is necessary to perform optical resolution somewhere along the route from the raw material to the target substance. Therefore, an expensive optical resolving agent is required, and in some cases, an extra step of introducing a protective group or the like is required.

従って、本発明の目的は、原料としてD又はL−ロイシ
ンを用い、特段の保護を導入せず、酸クロリド合成Frie
del-Crafts反応、水素化ホウ素ナトリウムによる立体選
択的な還元反応、1,3−オキサゾリジン−2−オンへの
環化、N−アルキル化反応を用いることで、上記の問題
を解決し収率よく又5段階という短い工程数で光学活性
1,3−オキサゾリジン−2−オン誘導体を得る方法を提
供することにある。
Therefore, an object of the present invention is to use D or L-leucine as a raw material, introduce no special protection, and perform acid chloride synthesis Frie.
By using del-Crafts reaction, stereoselective reduction reaction with sodium borohydride, cyclization to 1,3-oxazolidin-2-one, and N-alkylation reaction, the above problems can be solved and the yield can be improved. In addition, the optical activity can be achieved with a short number of steps of 5
It is to provide a method for obtaining a 1,3-oxazolidin-2-one derivative.

すなわち本発明は、光学活性ロイシンに五塩化リンを反
応させ、 で表わされる化合物とし、これにルイス酸の存在下、ベ
ンセンを反応させ、 で表わされる化合物とし、これを水素化ホウ素ナトリウ
ムにより還元して、 で表わされる化合物として、これに 一般式 (X,Yはそれぞれハロゲン原子、低級アルコキシ基、ア
ミノ基、又はトリクロロメチルオキシ基を示す) で表わされる化合物を反応させ還化せしめて で表わされる化合物とし、更に炭酸アルカリ、又は重炭
酸アルカリの存在下一般式 (式中、Zはハロゲン原子、トシルオキシ基又はメシル
オキシ基を示し、nは4〜6の整数を示す) で表わされる化合物と反応させ所望により生成物を酸付
加塩とすることを特徴とする 一般式 (式中、nは前記と同じ) で表わされる化合物及びその酸付加塩の製法に関する。
That is, the present invention is a reaction of optically active leucine with phosphorus pentachloride, And reacting it with benzene in the presence of a Lewis acid, A compound represented by, and reducing this with sodium borohydride, As a compound represented by (X and Y are halogen atom, lower alkoxy group, amino group, or trichloromethyloxy group respectively) In the presence of an alkali carbonate or a bicarbonate, the compound represented by the general formula (Wherein Z represents a halogen atom, a tosyloxy group or a mesyloxy group, and n represents an integer of 4 to 6), and the product is converted to an acid addition salt if desired. formula (Wherein n is the same as above) and a method for producing an acid addition salt thereof.

本発明方法において、光学活性ロイシンに五塩化リンを
反応させ得られる、一般式(II)で表わされる化合物
は、公知の方法〔ケー.ディー.コップルら、ジャーナ
ル オブ ザ アメリカンケミカル ソサエティ,78,6
199(1956),K.D.Kopple et al,J.Am.Chem.Soc.,78,6
199(1956)〕に従って、あるいはこの公知の方法に準
じて容易に製造することができる。
In the method of the present invention, the compound represented by the general formula (II), which can be obtained by reacting optically active leucine with phosphorus pentachloride, is a known method [K. Dee. Koppuru et al., Journal of the American Chemical Society, 78, 6
199 (1956), KDKopple et al, J. Am. Chem. Soc., 78 , 6
199 (1956)] or according to this known method.

得られた前記一般式(II)で表わされる化合物は単離、
精製することなく、反応混合物のまま次のフリーデルク
ラフツ反応に使用することもできる。
The obtained compound represented by the general formula (II) is isolated,
The reaction mixture can be directly used for the next Friedel-Crafts reaction without purification.

一般式(III)で表わされる化合物は、前記一般式(I
I)で表わされる化合物とベンゼンとのフリーデルクラ
フツ反応により得ることができる。
The compound represented by the general formula (III) has the same general formula (I
It can be obtained by the Friedel-Crafts reaction of the compound represented by I) with benzene.

フリーデルクラフツ反応における溶媒としては、この種
の反応に通常に使用されているものを使用することがで
き、反応基質であるベンゼンを溶媒として使用すること
もできるし、ニトロメタン二硫化炭素なども使用するこ
ともできる。
As the solvent in the Friedel-Crafts reaction, those commonly used in this type of reaction can be used, benzene as a reaction substrate can be used as a solvent, and nitromethane carbon disulfide and the like can also be used. You can also do it.

触媒であるルイス酸としては、たとえば無水塩化アルミ
ニウム、四塩化錫、三フッ化ホウ素、塩化亜鉛、塩化チ
タンなどの一種またはこれらの二種以上を混合して使用
することができる。これらルイス酸の中でも無水塩化ア
ルミニウムなどが好ましい。
As the Lewis acid as the catalyst, for example, one kind of anhydrous aluminum chloride, tin tetrachloride, boron trifluoride, zinc chloride, titanium chloride or the like or a mixture of two or more kinds thereof can be used. Among these Lewis acids, anhydrous aluminum chloride and the like are preferable.

ルイス酸の使用量は、前記一般式(II)で表わされる化
合物に対して、通常、2〜10倍モルであり、好ましくは
2〜3倍モルである。
The amount of Lewis acid used is usually 2 to 10 times mol, preferably 2 to 3 times mol, of the compound represented by the general formula (II).

フリーデルクラフツ反応における反応温度は、50〜100
℃で、反応時間は、2〜6時間である。
The reaction temperature in the Friedel-Crafts reaction is 50-100.
At C, the reaction time is 2 to 6 hours.

次いで、前記一般式(III)で表わされる化合物は、還
元反応により、前記一般式(IV)で表わされる化合物に
変換される。
Next, the compound represented by the general formula (III) is converted into the compound represented by the general formula (IV) by a reduction reaction.

反応は、メタノール、エタノールなどのアルコール類、
テトラヒドロフランなどのエーテル類などの溶媒中で行
なうことができる。
The reaction is alcohols such as methanol and ethanol,
It can be carried out in a solvent such as ethers such as tetrahydrofuran.

還元反応における反応温度は、−5℃〜+15℃の範囲で
ある。
The reaction temperature in the reduction reaction is in the range of -5 ° C to + 15 ° C.

前記水素化ホウ素ナトリウムの使用量は、前記一般式
(III)で表わされる化合物に対して、0.5〜1倍モルで
ある。
The amount of sodium borohydride used is 0.5 to 1 times the mol of the compound represented by the general formula (III).

一般式(VI)で表わされる化合物は、前記一般式(IV)
で表わされる化合物に一般式(V)で表わされる化合物
を反応させ、環化せしめることにより得られる。一般式
(V)で表わされる化合物の例としては、たとえば、炭
酸ジエチル、ホスゲン、トリクロロメチルクロロホルメ
ート、クロロ炭酸エチル、尿素等があげられる。
The compound represented by the general formula (VI) is the compound represented by the general formula (IV)
The compound represented by the formula (V) is reacted with a compound represented by the formula (V) to cyclize the compound. Examples of the compound represented by the general formula (V) include diethyl carbonate, phosgene, trichloromethyl chloroformate, ethyl chlorocarbonate, urea and the like.

一般式(IV)で表わされる化合物と一般式(V)で表わ
される化合物との反応は、水酸化ナトリウム等のアルカ
リの存在下、エーテル、クロロホルム等の有機溶媒と水
との不均一溶媒中−10℃〜室温の温度で行なわれる。一
般式(V)がたとえばクロル炭素エチルなどの場合は更
にひき続いてナトリウムメトキシド、ナトリウムエトキ
シド、アルミニウムイソプロポキシド等の塩基の存在
下、トルエン、キシレン等の有機溶媒中50℃〜還流温度
で加熱することにより行なわれ、該環化反応は、副生す
るアルコールを反応溶媒と共に留去することが好まし
い。
The reaction between the compound represented by the general formula (IV) and the compound represented by the general formula (V) is carried out in the presence of an alkali such as sodium hydroxide in a heterogeneous solvent of an organic solvent such as ether or chloroform and water. It is carried out at temperatures between 10 ° C and room temperature. When the general formula (V) is, for example, ethyl chlorocarbon, it is further followed by the presence of a base such as sodium methoxide, sodium ethoxide or aluminum isopropoxide in an organic solvent such as toluene or xylene at 50 ° C to the reflux temperature. It is preferable to carry out the cyclization reaction by distilling off the alcohol by-produced together with the reaction solvent.

又、一般式(V)が炭酸ジエチルなどの場合は反応はナ
トリウムエトキシド、ナトリウムメトキシド等の塩基の
存在下、式(IV)で表わされる化合物と一般式(V)の
化合物を無溶媒で50℃〜還流温度で加熱することにより
行なわれる。一般式(V)が尿素の場合は反応は式(I
V)で表わされる化合物と一般式(V)の化合物を無溶
媒で150〜250℃に加熱することにより行なわれる。
When the general formula (V) is diethyl carbonate or the like, the reaction is carried out in the presence of a base such as sodium ethoxide or sodium methoxide without reacting the compound represented by the formula (IV) with the compound of the general formula (V) without a solvent. It is carried out by heating at 50 ° C to the reflux temperature. When the general formula (V) is urea, the reaction is
It is carried out by heating the compound represented by V) and the compound of general formula (V) to 150 to 250 ° C. without a solvent.

一般式(VI)で表わされる化合物と一般式(VII)で表
わされる化合物の反応は、炭酸アルカリ又は、重炭酸ア
ルカリ、好ましくは炭酸カリウム又は炭酸水素カリウム
の存在下、アセトン、メチルエチルケトン、イソブチル
ケトン等の有機溶媒中、50℃〜還流温度で2〜50時間加
熱することによりおこなわれる。反応においては、1モ
ルの化合物(VI)に対し、化合物(VII)は1〜2モ
ル、炭酸カリウム若しくは炭酸水素カリウムを2〜8モ
ル用いることが好ましい。また、一般式(VII)で表わ
される化合物は、安定な酸付加塩たとえば塩酸塩の形で
使用することもできる。
The reaction between the compound represented by the general formula (VI) and the compound represented by the general formula (VII) is carried out in the presence of an alkali carbonate or an alkali bicarbonate, preferably potassium carbonate or potassium hydrogencarbonate, acetone, methyl ethyl ketone, isobutyl ketone, etc. It is carried out by heating at 50 ° C. to the reflux temperature for 2 to 50 hours in the organic solvent. In the reaction, it is preferable to use 1 to 2 mol of the compound (VII) and 2 to 8 mol of potassium carbonate or potassium hydrogen carbonate with respect to 1 mol of the compound (VI). Further, the compound represented by the general formula (VII) can also be used in the form of a stable acid addition salt such as a hydrochloride.

一般式(VII)で表わされる化合物は、下記一般式(VII
I)で表わされる化合物(J.Am.Chem.Soc.,76,2317-2
2(′54))に トシル酸、メシル酸又はそれらの反応性誘導体を作用さ
せるか、一般式(VIII)で表わされる化合物に塩化チオ
ニルを反応せさることにより得られる。
The compound represented by the general formula (VII) has the following general formula (VII
Compound represented by I) (J. Am. Chem. Soc., 76, 2317-2
2 ('54)) It can be obtained by reacting tosylic acid, mesylic acid or their reactive derivatives, or by reacting the compound represented by the general formula (VIII) with thionyl chloride.

一般式(VII)でZが塩素の場合は、下記の方法(F.Leo
nard & L.Simet,J.Am.Chem.Soc.,77,2855-60(′5
5))により得ることもできる。
When Z is chlorine in the general formula (VII), the following method (F.Leo
nard & L. Simet, J. Am. Chem. Soc., 77, 2855-60 ('5
It can also be obtained by 5)).

すなわち、1−ブロモ−3−クロロプロパン(IX)に一
般式(X)で表わされる化合物を、反応に関与しない溶
媒、たとえばイソプロピルエーテル(IPE)中で反応さ
せることにより得られる。
That is, it can be obtained by reacting 1-bromo-3-chloropropane (IX) with a compound represented by the general formula (X) in a solvent that does not participate in the reaction, for example, isopropyl ether (IPE).

反応温度は、30〜40℃が好ましい。The reaction temperature is preferably 30 to 40 ° C.

上記本発明方法により得られた一般式(I)で表わされ
る化合物は常法により、その酸付加塩、たとえば、塩酸
塩、フマル酸塩、メシル酸塩、シュウ酸塩、マレイン酸
塩、酒石酸塩等に導くことができる。
The compound represented by the general formula (I) obtained by the above-mentioned method of the present invention can be obtained by a conventional method using an acid addition salt thereof, for example, hydrochloride, fumarate, mesylate, oxalate, maleate, tartrate. And so on.

次に実施例、参考例を挙げ本発明を更に詳細に説明す
る。
Next, the present invention will be described in more detail with reference to Examples and Reference Examples.

実施例1 (S)−2−アミノ−4−メチル−1−フェニルペンタ
ン−1−オン塩酸塩 乾燥ベンゼン3.0lに五塩化リン319gを懸濁させ、約10℃
に冷却して撹拌しながらL−ロイシン197gを加えて、10
〜20℃に4時間撹拌した。その後、約5℃に冷却しなが
ら無水塩化アルミニウム600gを加えた。反応混合物を徐
々に加熱し、2時間かけて還流温度に上昇させ、更に2
時間加熱還流した。冷却後、反応混合物を氷3.0kgと濃
塩酸450mlとの混合物へ攪拌下に注いだ。その後、水層
を分取し、さらに有機層を水1及び0.2lで抽出し、水
層を合せ、これを一晩静置することにより析出した結晶
を濾取し、エーテルで洗浄した後、減圧下に乾燥して白
色結晶の標題化合物254g(収率75.0g)を得た。イソプ
ロパノールから再結晶した標題化合物の物性値は次の通
りである。
Example 1 (S) -2-Amino-4-methyl-1-phenylpentan-1-one hydrochloride 319 g of phosphorus pentachloride was suspended in 3.0 l of dry benzene, and the suspension was heated to about 10 ° C.
197 g of L-leucine was added to the mixture with cooling and stirring,
Stir at ~ 20 ° C for 4 hours. Then, while cooling to about 5 ° C., 600 g of anhydrous aluminum chloride was added. The reaction mixture is heated slowly and allowed to reach reflux temperature over 2 hours, and further 2
Heated to reflux for hours. After cooling, the reaction mixture was poured into a mixture of 3.0 kg of ice and 450 ml of concentrated hydrochloric acid with stirring. Then, the aqueous layer was separated, the organic layer was further extracted with 1 and 0.2 l of water, the aqueous layers were combined, and the crystals were precipitated by allowing this to stand overnight and washing with ether, The crystals were dried under reduced pressure to give 254 g (yield 75.0 g) of the title compound as white crystals. The physical properties of the title compound recrystallized from isopropanol are as follows.

mp;206〜208℃(分解) ▲〔α〕23 D▼;−5.4°(C1.007,水) 実施例2 (1R,2S)−2−アミノ−4−メチル−1−フェニルペ
ンタン−1−オール メタノール3.0lに(S)−2−アミノ−4−メチル−1
−フェニルペンタン−1−オン塩酸塩254gを溶解し、10
℃以下に冷却しながら水素化ホウ素ナトリウム56.7gを
加えた。同温度で30分間攪拌した後、反応混合物を減圧
下に濃縮した。濃縮残留物にクロロホルム1.5l、水0.75
l、続いて2Nのカ性ソーダ水溶液0.75lを加えて攪拌し
た。有機層を分取し、この有機層を飽和食塩水で洗浄
し、芒硝で乾燥後、溶媒を留去して得た白色の粗結晶を
n−ヘキサンで再結晶して白色針状結晶の標題化合物17
8g(収率81.9%)を得た。
mp; 206 - 208 ° C. (decomposition) ▲ [α] 23 D ▼; -5.4 ° (C1.007 , water) Example 2 (1R, 2S) -2-Amino-4-methyl-1-phenylpentan-1-ol (S) -2-amino-4-methyl-1 in 3.0 l of methanol.
Dissolve 254 g of phenylpentan-1-one hydrochloride,
56.7 g of sodium borohydride was added while cooling to below ℃. After stirring at the same temperature for 30 minutes, the reaction mixture was concentrated under reduced pressure. Chloroform 1.5 l, water 0.75 in the concentrated residue
1 and subsequently 0.75 l of a 2N aqueous solution of caustic soda were added and stirred. The organic layer was separated, washed with saturated brine, dried over sodium sulfate, and the solvent was evaporated to give crude white crystals which were recrystallized from n-hexane to give white needle crystals. Compound 17
8 g (yield 81.9%) was obtained.

mp;70〜71℃ ▲〔α〕23 D▼;−39.0°(C1.01,エタノール) 実施例3 (4S,5R)−4−(2−メチルプロピル)−5−フェニ
ル−1,3−オキサゾリジン−2−オン (A) (1R,2S)−2−アミノ−4−メチル−1−フェニルペ
ンタン−1−オール96.64g(0.5mol)をクロロホルム80
0mlに溶解し、水400mlを加えた後、氷冷する。攪拌下10
℃以下でクロロ炭酸エチル47.5mlを滴下する。さらに10
℃以下でクロロ炭酸エチル47.5mlを7.5N水酸化ナトリウ
ム水溶液150mlと同時に滴下し、両方の滴下を同時に終
了させる。さらに、同温度で30分間攪拌を続けた後、有
機層を分取し、水層をクロロホルム80mlで抽出する。合
わせた有機層を芒硝で乾燥し、減圧下クロロホルムを留
去する。残留物をトルエン1.5lに溶解し、トルエン200m
lを留去する。アルミニウムイソプロポキシド2.0gを加
え、1時間加熱還流した後、副生したアルコールを除去
するために、トルエン800mlを留去する。残留物にn−
ヘキサン600mlを攪拌下加え、室温で一夜放置する。析
出した白色結晶を濾取、トルエン−n−ヘキサン(1:
1)300mlで2回、n−ヘキサン300mlで1回洗浄した
後、乾燥して標題化合物104.0gを得る。(収率95%) mp;163〜164℃ ▲〔α〕25 D▼;−137.4°(C1.016,CHCl3(B) (1R,2S)−2−アミノ−4−メチル−1−フェニルペ
ンタン−1−オール0.97g(5mmol)及び尿素0.60g(10m
mol)の混合物を攪拌下170〜180℃で30分間さらに、200
〜210℃で20分間加熱した。冷却後クロロホルム及び水
を加えクロロホルムで抽出し乾燥した(Na2SO4)。クロ
ロホルム溶液をセライト濾過した後、減圧下濃縮した。
残留した黄色結晶(1.04g)を80%メタノール(6ml)か
ら再結晶して標題の化合物を白色結晶として0.68g得た
(収率62%)。
mp; 70-71 ℃ ▲ [α] 23 D ▼; -39.0 ° (C1.01, ethanol) Example 3 (4S, 5R) -4- (2-Methylpropyl) -5-phenyl-1,3-oxazolidin-2-one (A) (1R, 2S) -2-amino-4-methyl-1- Phenylpentan-1-ol 96.64 g (0.5 mol) was added to chloroform 80
Dissolve in 0 ml, add 400 ml of water, and cool with ice. Under stirring 10
47.5 ml of ethyl chlorocarbonate is added dropwise at a temperature below ℃. 10 more
At below ℃, 47.5 ml of ethyl chlorocarbonate is added dropwise at the same time with 150 ml of 7.5N sodium hydroxide aqueous solution, and both additions are completed at the same time. Furthermore, after continuing stirring at the same temperature for 30 minutes, the organic layer is separated and the aqueous layer is extracted with 80 ml of chloroform. The combined organic layers are dried over sodium sulfate and chloroform is distilled off under reduced pressure. Dissolve the residue in 1.5 l of toluene and add 200 m of toluene.
distill off l. After adding 2.0 g of aluminum isopropoxide and heating under reflux for 1 hour, 800 ml of toluene is distilled off in order to remove the alcohol by-produced. N- in the residue
Add 600 ml of hexane with stirring and leave at room temperature overnight. The precipitated white crystals were collected by filtration, and toluene-n-hexane (1:
1) It was washed twice with 300 ml and once with 300 ml of n-hexane and then dried to obtain 104.0 g of the title compound. (Yield 95%) mp; 163-164 ° C ▲ [α] 25 D ▼; -137.4 ° (C1.016, CHCl 3 ) (B) (1R, 2S) -2-Amino-4-methyl-1-phenylpentan-1-ol 0.97 g (5 mmol) and urea 0.60 g (10 m
mol) mixture under stirring at 170-180 ° C for 30 minutes and then 200
Heat at ˜210 ° C. for 20 minutes. After cooling, chloroform and water were added and the mixture was extracted with chloroform and dried (Na 2 SO 4 ). The chloroform solution was filtered through Celite and then concentrated under reduced pressure.
The residual yellow crystals (1.04 g) were recrystallized from 80% methanol (6 ml) to obtain 0.68 g of the title compound as white crystals (yield 62%).

実施例4 (4S,5R)−4−(2−メチルプロピル)−3−〔3−
(ペルヒドロアゼピン−1−イル)プロピル〕−5−フ
ェニル−1,3−オキサゾリジン−2−オン塩酸塩 塩酸1−(3−クロロプロピル)ペルヒドロアゼピン1
7.25g(81.25mmol)を水26mlに溶解し、2N−NaOH水溶液
45.5mlを加え、メチルエチルケトン100mlで抽出した。
抽出液を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾
燥した。乾燥剤を濾別した後、濾液に粉末の無水炭酸カ
リウム22.4g(162.5mmol)及び(4S,5R)−4−(2−
メチルプロピル)−5−フェニル−1,3−オキサゾリジ
ン−2−オン14.25g(65mmol)を加え、攪拌しながら12
時間加熱還流した。反応混合物を室温まで冷却し不溶物
を濾別した後溶媒を減圧下濃縮した。残留物をクロロホ
ルムに溶解し、2N−HCl水溶液130mlを加え、30分間攪拌
した。クロロホルム層を分取し、2N−HCl水溶液で洗浄
し、無水硫酸ナトリウムで乾燥した。乾燥剤を濾別し、
溶媒を減圧下留去して白色結晶25.17g(収率98.7%)を
得た。この結晶をイソプロパノールに加熱溶解し、n−
ヘキサンを加え、再結晶し、白色結晶の標題化合物20.6
gを得た。
Example 4 (4S, 5R) -4- (2-methylpropyl) -3- [3-
(Perhydroazepin-1-yl) propyl] -5-phenyl-1,3-oxazolidin-2-one hydrochloride 1- (3-chloropropyl) perhydroazepine hydrochloride 1
7.25 g (81.25 mmol) was dissolved in 26 ml of water, and 2N-NaOH aqueous solution was added.
45.5 ml was added and extracted with 100 ml of methyl ethyl ketone.
The extract was washed with saturated saline and dried over anhydrous sodium sulfate. After the desiccant was filtered off, 22.4 g (162.5 mmol) anhydrous potassium carbonate and (4S, 5R) -4- (2-
Methylpropyl) -5-phenyl-1,3-oxazolidin-2-one (14.25 g, 65 mmol) was added, and the mixture was stirred with 12
Heated to reflux for hours. The reaction mixture was cooled to room temperature, the insoluble material was filtered off, and the solvent was concentrated under reduced pressure. The residue was dissolved in chloroform, 130 ml of 2N-HCl aqueous solution was added, and the mixture was stirred for 30 minutes. The chloroform layer was separated, washed with a 2N-HCl aqueous solution, and dried over anhydrous sodium sulfate. The desiccant is filtered off,
The solvent was distilled off under reduced pressure to obtain 25.17 g of white crystals (yield 98.7%). The crystals were dissolved in isopropanol by heating and n-
Hexane was added and recrystallized to give 20.6 of the title compound as white crystals.
got g.

mp;182〜184℃(分解) ▲〔α〕23 D▼;+14.5°(C5,MeOH) 実施例5 (4S,5R)−4−(2−メチルプロピル)−5−フェニ
ル−3−(3−ピペリジノプロピル)−1,3−オキサゾ
リジン−2−オンメタンスルホン酸塩 塩酸1−(3−クロロプロピル)ピペリジン12.38g(6
2.5mmol)を水(12.4ml)に溶解し、2NNaOH水溶液(35m
l)を加え、メチルエチルケトンで抽出する。抽出液を
合わせて飽和食塩水で洗浄し、無水硫酸ナトリウムで乾
燥したのち、吸引濾過、メチルエチルケトンで洗浄す
る。合わせた濾液と洗液に、無水炭酸カリウム(粉末)
17.25g(125mmol)及び(4S,5R)−4−(2−メチルプ
ロピル)−5−フェニル−1,3−オキサゾリジン−2−
オン10.96g(50mmol)を加え、攪拌しながら12時間加熱
還流する。反応混合物を室温まで放冷または冷却し、吸
引濾過、メチルエチルケトンで洗浄する。濾液及び洗液
を合わせて減圧下濃縮したのち、残留する微黄色油状物
をクロロホルム(100ml)に溶解し、2NHCl水溶液(100m
l)を加え30分間攪拌する。クロロホルム層を分取し、2
NHCl水溶液で洗浄したのち、2NNaOH水溶液(100ml)を
加え30分間攪拌する。クロロホルム層を分取し、飽和食
塩水で洗浄し、無水硫酸ナトリウムで乾燥したのち、吸
引濾過、クロロホルム洗浄する。濾液及び洗液を合わせ
て減圧下クロロホルムを留去することにより微黄色油状
物を得る。この油状物をエタノール−酢酸エチル(1:1
0)混合溶媒(65ml)に溶解し、メタンスルホン酸4.80g
(50mmol)をエタノール−酢酸エチル(1:10)混合溶媒
(4ml)と共に加え、室温で攪拌する。析出した結晶を
濾取エタノール−酢酸エチル(1:20)混合溶媒及び酢酸
エチルで洗浄、乾燥して標題化合物の白色結晶といて1
6.52g得る(収率75%) mp;129〜131℃ ▲〔α〕23 D▼;+11.7°(C5,O,MeOH) 参考例1 塩酸1−(3−クロロプロピル)ペルヒドロアゼピン 1−ブロモ−3−クロロプロパン157.4g(1mol)をイソ
プロピルエーテル(IPE)(240ml)に溶解する。攪拌下
ヘキサメチレンイミン(198.4g,2mol)を約1.5時間で滴
下する。この時、反応温度が30〜40℃になるように滴下
速度を調節する。その後35〜40℃で10時間加熱攪拌し、
一夜室温で放置する。反応混合物を水及び飽和食塩水で
洗浄し、芒硝で乾燥する。芒硝を濾別、IPE(50ml×
3)で洗浄する。濾液と洗液を合わせ、氷冷した飽和HC
l−イソプロパノール(IPA)溶液(130ml)とイソプロ
パノール(270ml)の混合物中に攪拌下加える。析出し
た結晶を濾取、IPA−IPE(1:1)(200ml×2)で洗浄、
乾燥して標題化合物を159.3g得る。(収率75%)(mp;2
06〜207℃(分解))
mp; 182-184 ° C. (decomposition) ▲ [α] 23 D ▼; + 14.5 ° ( C5, MeOH) Example 5 (4S, 5R) -4- (2-methylpropyl) -5-phenyl-3- (3-piperidinopropyl) -1,3-oxazolidin-2-one methanesulfonate hydrochloride 1- ( 3-chloropropyl) piperidine 12.38 g (6
2.5 mmol) is dissolved in water (12.4 ml) and 2N NaOH aqueous solution (35 m
l) is added and extracted with methyl ethyl ketone. The extracts are combined, washed with saturated brine, dried over anhydrous sodium sulfate, filtered with suction, and washed with methyl ethyl ketone. Anhydrous potassium carbonate (powder) in the combined filtrate and wash
17.25 g (125 mmol) and (4S, 5R) -4- (2-methylpropyl) -5-phenyl-1,3-oxazolidine-2-
Add 10.96 g (50 mmol) of on and heat to reflux for 12 hours with stirring. The reaction mixture is allowed to cool or cool to room temperature, suction filtered and washed with methyl ethyl ketone. After the filtrate and washings were combined and concentrated under reduced pressure, the remaining slightly yellow oily substance was dissolved in chloroform (100 ml) and a 2N HCl aqueous solution (100 m
Add l) and stir for 30 minutes. Separate the chloroform layer and
After washing with NH Cl aqueous solution, 2N NaOH aqueous solution (100 ml) is added and stirred for 30 minutes. The chloroform layer is separated, washed with saturated brine, dried over anhydrous sodium sulfate, suction filtered and washed with chloroform. The filtrate and washings are combined and chloroform is distilled off under reduced pressure to obtain a pale yellow oily substance. This oil was added to ethanol-ethyl acetate (1: 1).
0) Dissolved in mixed solvent (65ml), methanesulfonic acid 4.80g
(50 mmol) is added together with ethanol-ethyl acetate (1:10) mixed solvent (4 ml), and the mixture is stirred at room temperature. The precipitated crystals were collected by filtration, washed with a mixed solvent of ethanol-ethyl acetate (1:20) and ethyl acetate, and dried to give white crystals of the title compound.
6.52 g is obtained (75% yield) mp; 129-131 ° C ▲ [α] 23 D ▼; + 11.7 ° (C5, O, MeOH) Reference Example 1 1- (3-chloropropyl) perhydroazepine hydrochloride 157.4 g (1 mol) of 1-bromo-3-chloropropane is dissolved in isopropyl ether (IPE) (240 ml). Hexamethyleneimine (198.4 g, 2 mol) is added dropwise with stirring over about 1.5 hours. At this time, the dropping rate is adjusted so that the reaction temperature is 30 to 40 ° C. Then heat and stir at 35-40 ° C for 10 hours,
Leave at room temperature overnight. The reaction mixture is washed with water and saturated brine, and dried over Glauber's salt. Glauber's salt was filtered off and IPE (50 ml x
Wash with 3). The filtrate and washings are combined and ice-cooled saturated HC
Add to a mixture of l-isopropanol (IPA) solution (130 ml) and isopropanol (270 ml) with stirring. The precipitated crystals were collected by filtration, washed with IPA-IPE (1: 1) (200 ml x 2),
Dry to obtain 159.3 g of the title compound. (Yield 75%) (mp; 2
06 ~ 207 ℃ (decomposition))

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】光学活性ロイシンに五塩化リンを反応さ
せ、 で表わされる化合物とし、これにルイス酸の存在下、ベ
ンゼンを反応させ、 で表わされる化合物とし、これを水素化ホウ素ナトリウ
ムにより還元して、 で表わされる化合物とし、次いでこれに一般式 (X,Yは、それぞれハロゲン原子、低級アルコキシ基、
アミノ基、又はトリクロロメチルオキシ基を示す) で表わされる化合物を反応させ環化せしめて で表わされる化合物とし、更にこれを炭酸アルカリ又は
重炭酸アルカリの存在下、一般式 (式中、Zはハロゲン原子、トシルオキシ基又はメシル
オキシ基を示し、nは4〜6の整数を示す) で表わされる化合物と反応させ所望により生成物を酸付
加塩とすることを特徴とする、一般式 (式中、nは前記と同じ) で表わされる化合物及びその酸付加塩の製法。
1. An optically active leucine is reacted with phosphorus pentachloride, A compound represented by, and reacting this with benzene in the presence of a Lewis acid, A compound represented by, and reducing this with sodium borohydride, A compound represented by the general formula (X and Y are a halogen atom, a lower alkoxy group,
Amino group or trichloromethyloxy group) A compound represented by the general formula: in the presence of alkali carbonate or bicarbonate. (Wherein Z represents a halogen atom, a tosyloxy group or a mesyloxy group, and n represents an integer of 4 to 6), and the product is converted to an acid addition salt if desired. General formula (In the formula, n is the same as above) and a method for producing an acid addition salt thereof.
JP62027741A 1987-02-09 1987-02-09 Process for producing 1,3-oxazolidin-2-one derivative Expired - Lifetime JPH0759571B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62027741A JPH0759571B2 (en) 1987-02-09 1987-02-09 Process for producing 1,3-oxazolidin-2-one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62027741A JPH0759571B2 (en) 1987-02-09 1987-02-09 Process for producing 1,3-oxazolidin-2-one derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP6332524A Division JP2554603B2 (en) 1994-12-13 1994-12-13 Process for producing optically active 4- (2-methylpropyl) -5-phenyl-1,3-oxazolidin-2-one

Publications (2)

Publication Number Publication Date
JPS63196574A JPS63196574A (en) 1988-08-15
JPH0759571B2 true JPH0759571B2 (en) 1995-06-28

Family

ID=12229456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62027741A Expired - Lifetime JPH0759571B2 (en) 1987-02-09 1987-02-09 Process for producing 1,3-oxazolidin-2-one derivative

Country Status (1)

Country Link
JP (1) JPH0759571B2 (en)

Also Published As

Publication number Publication date
JPS63196574A (en) 1988-08-15

Similar Documents

Publication Publication Date Title
US5225585A (en) Production of fluoxetine and new intermediates
US5298657A (en) Preparation of substituted guanidines
US4301163A (en) Amino-ether oxides and use thereof in therapy
HU193161B (en) Process for preparing new n-alkyl-norscopines
SU508199A3 (en) Method for producing morpholine derivatives
AU746721B2 (en) Chemical synthesis of morpholine derivatives
KR940005012B1 (en) Novel azetidine, its manufacturing process and its use as an intermediate for the preparation of bactericidal compositions
EP0077427B1 (en) Piperidine derivatives, their preparation and use in medicine
KR20030024919A (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
JPH0759571B2 (en) Process for producing 1,3-oxazolidin-2-one derivative
EP0585116B1 (en) 1-Alkoxy-naphthalene-2-carboxamide derivatives with high affinity for the serotonin 5-HT1A receptor
JP2001521498A (en) Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide
JP4173599B2 (en) Process for producing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline
CH628885A5 (en) Piperidine derivative
CA1133483A (en) Hexahydro-trans-pyridoindole neuroleptic agents
US3433802A (en) 3-(n-lower-alkylanilino)pyrrolidines
JP2554603B2 (en) Process for producing optically active 4- (2-methylpropyl) -5-phenyl-1,3-oxazolidin-2-one
US4003932A (en) Aminoalkylethers
JPH06340623A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
US4533732A (en) 3-Propionylsalicylic acid derivatives and process for the preparation of the same
JPS6016931B2 (en) Method for producing substituted benzoic acid amide
US4049825A (en) Aminoalkylethers; composition and method of use
JPH0559045A (en) Production of pyridyloxy derivative
CN119768406A (en) Process for the preparation of substituted pyrrolopyrimidines and intermediates
FR2753968A1 (en) NOVEL HETEROARYLOXYETHYLAMINES, PROCESS FOR THE PREPARATION THEREOF, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS COMPRISING SAME